Evidence map›Paper›PMID 42445806›Full record

ArticleACS applied nano materials2025

Mercury (II) Ion Sensing Through in Situ Synthesis of Gold Nanoparticles.

Jin-Ho Park, Kyeonghyeon Nam, Young Kwan Cho, Marylyn Setsuko Arai, Dong-Hwan Kim, Hakho Lee

Abstract read
In one paragraph

Article in ACS applied nano materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jin-Ho ParkCenter for Systems Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Kyeonghyeon NamFritz-Haber-Institut der Max-Planck-Gesellschaft, Faradayweg 4-6, 14195 Berlin, Germany.
Young Kwan ChoCenter for Systems Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Marylyn Setsuko AraiCenter for Systems Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Dong-Hwan KimSchool of Chemical Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Hakho LeeCenter for Systems Biology, Massachusetts General Hospital, Boston, MA 02114, USA.

Funding

Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic ArrayU01CA284982 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Cesar M Castro, Hakho Lee · 2023 to 2026
$3.7M
Clinical platform for high-throughput analyses of extracellular vesiclesR01CA229777 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO, SKOG, JOHAN · 2018 to 2022
$3.2M
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment MonitoringR01CA239078 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BALAJ, LEONORA, LEE, HAKHO · 2020 to 2024
$3.1M
High-throughput Phenotyping of iPSC-derived Airway Epithelium by Multiscale Machine Learning MicroscopyR01HL163513 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Hakho Lee, Kwonmoo Lee · 2023 to 2026
$3.1M
Standardized Molecular Analyses of Glioma EVsR01CA237500 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CARTER, BOB S, LEE, HAKHO · 2020 to 2024
$3.0M
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancerR01CA264363 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CASTRO, CESAR M, LEE, HAKHO · 2021 to 2024
$2.4M
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachU01CA279858 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Cesar M Castro, Hakho Lee · 2023 to 2026
$2.1M
3D Fourier Imaging System for High Throughput Analyses of Cancer OrganoidsR21CA267222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO · 2022 to 2024
$613k
NCI NIH HHS R01 CA229777NCI NIH HHS R01 CA237500NCI NIH HHS R01 CA239078NCI NIH HHS R01 CA264363NCI NIH HHS R21 CA267222NCI NIH HHS U01 CA279858NCI NIH HHS U01 CA284982NHLBI NIH HHS R01 HL163513
6 · The paper itself

Abstract

Divalent mercury ion (Hg

Indexed as

chelationin-situ gold nanoparticle productionMercury ionpyruvateUV light

Identifiers

PMID42445806
PMCPMC13364152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.